Loading clinical trials...

COMPLETEDNA

Blended Mindfulness-Based Intervention for Persistent Depression

Testing the Feasibility and Acceptability of a Blended Mindfulness-Based Intervention for Persistent Depression

NCT04576741•University of Surrey

View on ClinicalTrials.gov

Summary

We plan to share all IPD but not any personal information.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. A current diagnosis of Major Depression as assessed by Structured Clinical Interview for DSM IV (First, Spitzer, Gibbon, \& Williams, 2002).
•2. A chronic or recurrent lifetime history of depression, with either chronic persistence of symptoms or a history of at least three previous episodes of depression, two of which needed to have occurred during the last two years.
•3. Self-reported severity of current symptoms on a clinical level as indicated by a PHQ-9 score of 10 or more.
•4. Age 18 to 65 thus excluding cases of late life depression given that such cases might diﬀer in aetiology.
•5. Fluency in spoken and written English.
•6. Have individual access to a computer or mobile device with internet connection and video link.

Exclusion Criteria

•1. History of schizophrenia, schizoaffective disorder, bipolar disorder, current abuse of alcohol or other substances, organic mental disorder, pervasive developmental delay, primary diagnosis of obsessive-compulsive disorder or eating disorder, or regular nonsuicidal self-injury.
•2. Current treatment with CBT more than once a month.
•3. Regular meditation practice (meditating more than once per week).
•4. Inability to complete research assessments through difficulty with English, visual impairment, or cognitive difficulties.
•5. We will allow patients who are currently taking antidepressants into the study provided that the medication has not been changed during the last four weeks before entry into the study.

Locations (1)

Surrey and Borders Partnership NHS Foundation Trust

Guildford, Surrey, United Kingdom

Key Dates

Start Date

March 1, 2021

Primary Completion Date

May 1, 2022

Completion Date

May 27, 2022

Last Updated

January 6, 2025

Enrollment

ACTUAL participants

Conditions

Persistent Depressive Disorder

Interventions

bMBI standard practice

BEHAVIORAL

bMBI shorter more frequent practice

BEHAVIORAL

Effects of Mindfulness on Brain Functioning in Depressed Patients

NCT05650177

Persistent Depressive Disorder

View study

COMPLETEDNA

Intensive Psychotherapy for Chronic Depression

NCT05221567

Chronic DepressionPersistent Depressive Disorder+1 more

View study

UNKNOWN

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Blended Mindfulness-Based Intervention for Persistent Depression

Inclusion Criteria

Exclusion Criteria

Effects of Mindfulness on Brain Functioning in Depressed Patients

Intensive Psychotherapy for Chronic Depression

Feasibility and Effectiveness of a Personalized Inpatient Program for Persistent Depressive Disorder